With the aim to coordinate clinical trials in oncology according to the standards of Good clinical Practice in the area of Central- and Southeastern Europe, the foundation of CECOG was laid in 1999.
CECOG defined its mode of interaction based upon respect and mutual esteem in its Atlanta Declaration in 2000. Shortly thereafter, CECOG established a scientific and an advisory board necessary for its functioning and embarked upon two phase III clinical trials in metastatic breast cancer (MBC) and in non-small cell lung cancer (NSCLC), respectively. Both studies were published.
In the meantime, CECOG has evolved into a true international cooperative study group being impressively active in the region of Central- and South Eastern Europe and beyond. CECOG cooperates with more than 150 academic centers in a total of 23 countries, including Austria, Bosnia, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Israel, Latvia, Lebanon, Lithuania, Montenegro, Poland, Portugal, Romania, Russia, Serbia, Slovenia, Slovakia, South Africa and Turkey.
CECOG’s range of activity is not only limited to the conduct of clinical trials but also concentrates on education and the definition of quality standards in regard to the care of patients with malignant diseases.